Optilite IgM CSF Kit
Method, Nephelometric, Immunoglobulins (G, A, M). 510(k) K190686, from The Binding Site Group , Ltd. (Edgbaston, GB). Product code CFN, class 2.
As of Nov 18, 2026, K190686 is an FDA 510(k) held by The Binding Site Group , Ltd., substantially equivalent on May 28, 2019 after 71 days, with no recalls tied to it in FDA's recall database.
- Review time: 71 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Optilite IgM CSF Kit is intended for the quantitative in vitro measurement of IgM in cerebrospinal fluid (CSF) samples using the Optilite analyser.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Human Igm Csf KitK120750 · The Binding Site Group , Ltd. · May 17, 2013
Cited as a predicate
1 later 510(k) summary names this device as a predicate- GEO Bone Screw SystemK202817 · Gramercy Extremity Orthopedics, LLC · Oct 22, 2020
Other CFN clearances
The newest 510(k)s for the same product code; see every CFN device- N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)K233663 · Siemens Healthcare Diagnostics Products GmbH · Dec 13, 2023
- Immunoglobulin G (IgG)K221114 · Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. · Aug 2, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 18, 2019
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files